EV Biologics Inc (YECO)
0.6021
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
EV Biologics Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2016 | 5.007M |
| September 30, 2016 | 10.59M |
| June 30, 2016 | 13.28M |
| March 31, 2016 | 6.763M |
| December 31, 2015 | 14.47M |
| September 30, 2015 | 8.113M |
| Date | Value |
|---|---|
| June 30, 2015 | 6.201M |
| March 31, 2015 | 11.91M |
| December 31, 2014 | 4.784M |
| September 30, 2014 | 12.00M |
| June 30, 2014 | 12.11M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| CEL-SCI Corp | -23.07M |
| AIM ImmunoTech Inc | -21.27M |
| IGC Pharma Inc | -6.19M |
| NovaBay Pharmaceuticals Inc | -4.131M |
| Protalix BioTherapeutics Inc | -1.318M |